$CSUI News out this week as Cannabis Suisse Corp. Expansion

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
153
$CSUI News out this week as Cannabis Suisse Corp. Expansion Plans for Online Sales, Adding to CBD product lines with New Hemp Brands

Company plans to expand online sales with retail giant, Amazon

DIETIKON, SWITZERLAND / ACCESSWIRE / September 21, 2020 / Cannabis Suisse Corp. (OTC:CSUI), a fully licensed Swiss cannabis cultivation and distribution company for recreational tobacco products and medical CBD oils, announces online expansion plans including the upcoming launch of a new brand on Amazon.

?annabis Suisse Corp. is developing its own line of products including hemp oil, hemp protein, hemp gummies and hemp hearts with all the appropriate certificates and licenses for sale on Amazon.

This news follows a recent announcement for online distribution of its cannabis and CBD products with uWeed from their retail outlets and online store (www.uweed.ch).

The expansion into online sales of hemp gives the company headquartered in Switzerland, wider access and inroads into the US markets and the legal environment for CBD products evolves.

Mr. Alain Parrik, COO & Director said, " Amazon, is an important distribution outlet for us as we ramp up for expansion across multiple online retail platforms. Introducing a new line of hemp products paves the wave for additional products in the future."

Cannabis Suisse Corp. will be in compliance with Amazon rules and respects their position that CBD is currently banned on Amazon but hemp products are not.

The Company, as a registered manufacturer of both products, will continue to use flowers with the highest concentration of CBD. For the new Amazon product line, oil will be squeezed from the seeds allowing Cannabis Suisse to use the whole plant in its production and benefit from it.

View photos
Source: Brightfield Group Quarterly CBD Consumer Survey, Q2, 2020, Sample size = 5,000

Price Compression

ABOUT CANNABIS SUISSE CORP.
Cannabis Suisse Corp. is a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections.
This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Cannabis Suisse Corp. to be materially different from the statements made herein.

CONTACT:

Alain Parrik
Cannabis Suisse Corp.
+41445865314
alain.parrik@cannabissuisse.biz

SOURCE: Cannabis Suisse Corp
What I post is my opinion. Do your own DD. Make your own investment decision. Links, images, & retweets are not endorsements.

1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.

4️⃣Not Financial Advice. What I post is my opinion.
Also Paid for Advertising/IR/PR on Emerging Companies
Full Disclaimer: https://corporateads.com/disclaimer/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

53% of European Telecom Users Eye Provider Switch

Updated Category News Views 2

Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...

Continue Reading
Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 1

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 4

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 2

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 14

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
ISO 45010: First Guidance for Menstruation, Menopause

Updated Category News Views 0

Tackling Menstruation and Menopause in the Workplace Today, the International Organization for Standardization (ISO) has taken a bold step forward by launching ISO 45010—a groundbreaking standard aimed at addressing menstruation and menopause in the workplace. Millions endure these natural processes throughout their careers, yet structured policies to support them have...

Continue Reading
Nuix Leverages AI for Transformative Legal Review

Updated Category News Views 1

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Continue Reading

Top 5 Most Recently Viewed Articles

MongoDB Reports Exceptional Earnings, Boosting Investor Confidence

Updated Category News Views 117

MongoDB's Remarkable Growth Continues MongoDB Inc (NASDAQ: MDB) has become the talk of the town as its shares soar following stellar earnings results that have impressed investors and analysts alike. The recent financial report showcased not just revenue growth but also a promising outlook that has captivated the attention of the market. Investors are keenly watching the...

Continue Reading
Federal Judge's Ruling on Trump's Workforce Watchdog Dismissal

Updated Category News Views 186

Federal Judge's Decision on Trump’s Actions A recent ruling from a federal judge has highlighted the legality of President Donald Trump's dismissal attempts regarding a federal workforce watchdog. This ruling not only affects Trump but also serves as a significant precedent in maintaining the independence of the Office of Special Counsel. Details of the Case Judge Amy...

Continue Reading
Gables Residential Celebrates ESG Commitment with Award Success

Updated Category News Views 188

Gables Residential Earns Esteemed Recognition for ESG Leadership Gables Residential, a recognized leader in the multifamily development and management sector, has achieved a remarkable milestone by receiving the Multi-Housing News (MHN) Excellence Gold Award. This accolade celebrates the company’s dedicated efforts toward Environmental, Social, and Governance (ESG)...

Continue Reading
Microsoft's Layoffs Spark Controversy Over AI Support

Updated Category News Views 221

Layoffs at Microsoft Prompt AI Support Discussion Microsoft Corporation (NASDAQ: MSFT) recently faced a crisis as it laid off approximately 9,100 employees, a move that set off a ripple effect of reactions within the tech community. The company's decision comes as it continues to streamline operations amid economic pressures. In the wake of these layoffs, feedback from an...

Continue Reading
Caris Life Sciences to Present Groundbreaking Research at ESMO 2024

Updated Category News Views 154

Caris Life Sciences to Present Innovative Research at ESMO 2024 Caris Life Sciences (Caris), in partnership with prominent cancer centers, is preparing to unveil significant research findings that highlight the clinical benefits of comprehensive molecular profiling at the European Society for Medical Oncology (ESMO) Congress 2024. The research will cover seven studies...

Continue Reading